vs

Side-by-side financial comparison of KAMADA LTD (KMDA) and ATRenew Inc. (RERE). Click either name above to swap in a different company.

KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $43.2M, roughly 1.1× ATRenew Inc.). ATRenew Inc. runs the higher net margin — 16.9% vs 11.3%, a 5.6% gap on every dollar of revenue.

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

ATRenew Inc. operates a leading pre-owned consumer electronics transaction and servicing ecosystem primarily in China. Its core services include end-to-end device recycling, professional quality inspection, certified refurbishment, and resale of smartphones, laptops, tablets and other digital products, serving both individual consumers and enterprise clients across domestic and select Southeast Asian markets.

KMDA vs RERE — Head-to-Head

Bigger by revenue
KMDA
KMDA
1.1× larger
KMDA
$47.0M
$43.2M
RERE
Higher net margin
RERE
RERE
5.6% more per $
RERE
16.9%
11.3%
KMDA

Income Statement — Q3 FY2025 vs Q1 FY2023

Metric
KMDA
KMDA
RERE
RERE
Revenue
$47.0M
$43.2M
Net Profit
$5.3M
$7.3M
Gross Margin
42.0%
Operating Margin
16.6%
Net Margin
11.3%
16.9%
Revenue YoY
12.6%
Net Profit YoY
37.1%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMDA
KMDA
RERE
RERE
Q3 25
$47.0M
Q2 25
$44.8M
Q1 25
$44.0M
Q3 24
$41.7M
Q2 24
$42.5M
Q1 24
$37.7M
Q3 23
$37.9M
Q2 23
$37.4M
Net Profit
KMDA
KMDA
RERE
RERE
Q3 25
$5.3M
Q2 25
$7.4M
Q1 25
$4.0M
Q3 24
$3.9M
Q2 24
$4.4M
Q1 24
$2.4M
Q3 23
$3.2M
Q2 23
$1.8M
Gross Margin
KMDA
KMDA
RERE
RERE
Q3 25
42.0%
Q2 25
42.3%
Q1 25
47.1%
Q3 24
41.3%
Q2 24
44.6%
Q1 24
44.4%
Q3 23
39.0%
Q2 23
38.6%
Operating Margin
KMDA
KMDA
RERE
RERE
Q3 25
16.6%
Q2 25
15.8%
Q1 25
17.7%
Q3 24
12.7%
Q2 24
13.3%
Q1 24
10.7%
Q3 23
11.5%
Q2 23
7.0%
Net Margin
KMDA
KMDA
RERE
RERE
Q3 25
11.3%
Q2 25
16.5%
Q1 25
9.0%
Q3 24
9.3%
Q2 24
10.4%
Q1 24
6.3%
Q3 23
8.5%
Q2 23
4.8%
EPS (diluted)
KMDA
KMDA
RERE
RERE
Q3 25
$0.09
Q2 25
$0.13
Q1 25
$0.07
Q3 24
$0.07
Q2 24
$0.08
Q1 24
$0.04
Q3 23
$0.06
Q2 23
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMDA
KMDA
RERE
RERE
Cash + ST InvestmentsLiquidity on hand
$72.0M
$228.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.2M
$557.1M
Total Assets
$377.2M
$722.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMDA
KMDA
RERE
RERE
Q3 25
$72.0M
Q2 25
$66.0M
Q1 25
$76.3M
Q3 24
$72.0M
Q2 24
$56.5M
Q1 24
$48.2M
Q3 23
$52.6M
Q2 23
$21.8M
Stockholders' Equity
KMDA
KMDA
RERE
RERE
Q3 25
$265.2M
Q2 25
$260.0M
Q1 25
$252.0M
Q3 24
$255.3M
Q2 24
$251.2M
Q1 24
$251.2M
Q3 23
$238.4M
Q2 23
$176.8M
Total Assets
KMDA
KMDA
RERE
RERE
Q3 25
$377.2M
Q2 25
$368.2M
Q1 25
$375.1M
Q3 24
$351.2M
Q2 24
$351.0M
Q1 24
$343.2M
Q3 23
$337.1M
Q2 23
$314.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMDA
KMDA
RERE
RERE
Operating Cash FlowLast quarter
$10.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMDA
KMDA
RERE
RERE
Q3 25
$10.4M
Q2 25
$8.0M
Q1 25
$-513.0K
Q3 24
$22.2M
Q2 24
$14.0M
Q1 24
$1.0M
Q3 23
$921.0K
Q2 23
$1.8M
Cash Conversion
KMDA
KMDA
RERE
RERE
Q3 25
1.97×
Q2 25
1.09×
Q1 25
-0.13×
Q3 24
5.75×
Q2 24
3.15×
Q1 24
0.43×
Q3 23
0.29×
Q2 23
1.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons